Skip to content

Savara SVRA Financing Cash Flow

Financing Cash Flow at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
-$8.84M-182%
Innoviva, Inc. logo
Innoviva, Inc.INVA
-$20.15M-11,109%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$5.58M-553%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$21.62M-118%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$1.39M+253%
TRV
Trevi Therapeutics, Inc.TRVI
$222K-97.4%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+134%
Enterprise value$1.19B+127%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's financing cash flow?
Savara (SVRA) reported financing cash flow of -$195K in Q1 2026.
How has Savara's financing cash flow changed year-over-year?
Savara's financing cash flow decreased by 108.4% year-over-year, from $2.32M to -$195K.
What is the long-term trend for Savara's financing cash flow?
Over 3 years (2021 to 2024), Savara's financing cash flow has grown at a -0.7% compound annual growth rate (CAGR), from $120.81M to $118.42M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.